Status:
COMPLETED
Quality of Life and Adverse Effects in Epilepsy Patients (EPIKA)
Lead Sponsor:
UCB Pharma
Conditions:
Epilepsy
Eligibility:
All Genders
18+ years
Brief Summary
Observational, multicentre, epidemiological study to determine the HRQOL of patients with epilepsy according to treatment sub-group and to validate the Spanish version of the Adverse Events Profile, p...
Eligibility Criteria
Inclusion
- Epileptic adult patients treated at a stable dose with one or more AEDs for ≥ 3 months
Exclusion
- Symptomatic epilepsy due to malignant brain tumour or progressive brain disease.
- Confirmed diagnosis of a concomitant chronic disease
Key Trial Info
Start Date :
March 1 2006
Trial Type :
OBSERVATIONAL
End Date :
October 1 2007
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT00302991
Start Date
March 1 2006
End Date
October 1 2007
Last Update
January 30 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Barcelona, Spain